Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Replimune (REPL) Total Liabilities (2018 - 2025)

Replimune has reported Total Liabilities over the past 8 years, most recently at $123.1 million for Q4 2025.

  • Quarterly results put Total Liabilities at $123.1 million for Q4 2025, up 1.48% from a year ago — trailing twelve months through Dec 2025 was $123.1 million (up 1.48% YoY), and the annual figure for FY2025 was $135.5 million, up 19.67%.
  • Total Liabilities reached $123.1 million in Q4 2025 per REPL's latest filing, down from $126.1 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $135.5 million in Q1 2025 and bottomed at $44.4 million in Q1 2021.
  • Median Total Liabilities over the past 5 years was $94.3 million (2023), compared with a mean of $89.2 million.
  • The largest annual shift saw Total Liabilities decreased 13.65% in 2021 before it surged 86.89% in 2023.
  • Over 5 years, Total Liabilities stood at $47.8 million in 2021, then soared by 74.17% to $83.2 million in 2022, then skyrocketed by 33.88% to $111.4 million in 2023, then rose by 8.85% to $121.3 million in 2024, then increased by 1.48% to $123.1 million in 2025.
  • Business Quant data shows Total Liabilities for REPL at $123.1 million in Q4 2025, $126.1 million in Q3 2025, and $132.8 million in Q2 2025.